Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by bluemoons20on Dec 13, 2021 10:58pm
115 Views
Post# 34227647

RE:RE:Just reading up a bit on the EBSCOhost

RE:RE:Just reading up a bit on the EBSCOhostChanging the multiple  is nice  and I would love it  but  since this is a specific application,  it is not a huge market and it really comes down to a finite number of units until you cap out.  So with the  financing (  and hence dilution)  Do you really get those kinds of multiples??

Or just a  current value of future potential sales    Maybe  $3  to  max  $5.   Would love it  but do not see this  @  $10.

\Would love to know what is happenning behind the scenes.  First we have money for three years  , then  a surprise financing  and building our own  units  and  now  talk of  just software?   Seems like a lot of bobbing and weaving going on here.  And then  the note about  end of  2022  (and that is just  to complete  , not  test  and then  sell???

As I have said  before  , as every day goes on this is looking like a longer and longer hold.  That is why  I personally  am not continuing to  buy  shares

GLTA
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse